Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|May 1, 2003

RF ablation knocks out renal cell carcinoma

Small tumors on the surface of the kidney can't escape from radio-frequency ablation treatment, according to researchers at Massachusetts General Hospital.

Small tumors on the surface of the kidney can't escape from radio-frequency ablation treatment, according to researchers at Massachusetts General Hospital.

In the largest such study to date, the group followed 34 patients who had been treated with RF ablation for 42 renal cell carcinoma tumors during a 3.5-year period. They were able to completely ablate all of the 29 exophytic tumors and both parenchymal tumors in one or more visits. The mean diameter of the tumors was 3.2 cm. The team could completely ablate only five of the 11 tumors that had a component in the renal sinus, which acts as a heat sink by continuously allowing cool blood to flow into the area. The study was published in the February issue of Radiology.

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.